Ureaplasma Infection and Neonatal Lung Disease

Seminars in Perinatology

Volumn 31, Issue 1, 2007, Pages 2-9

  Schelonka, Robert L ^a   Waites, Ken B ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

bronchopulmonary dysplasia; newborn infant; Ureaplasma

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; AZITHROMYCIN; CLARITHROMYCIN; COLLAGENASE; CYTOKINE; DNA; ELASTASE; ERYTHROMYCIN; ERYTHROMYCIN LACTOBIONATE; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROLIDE; MONOCLONAL ANTIBODY; OXYGEN; PHOSPHOLIPASE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; THROMBOXANE A2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG; VASCULOTROPIN;

ANTIBIOTIC THERAPY; COMORBIDITY; GRAM NEGATIVE INFECTION; HUMAN; INTRAUTERINE INFECTION; LUNG DYSPLASIA; LUNG INFECTION; NEWBORN; NEWBORN INFECTION; NONHUMAN; PATHOGENESIS; PERINATAL INFECTION; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; REVIEW; UREAPLASMA;

ANTI-BACTERIAL AGENTS; BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; DISEASE TRANSMISSION, VERTICAL; ERYTHROMYCIN; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREMATURE BIRTH; UREAPLASMA; UREAPLASMA INFECTIONS;

EID: 33847071236     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2007.01.001     Document Type: Review

References (87)

1. Lemons J.A., Bauer C.R., Oh W., et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 107 (2001) E1
2. Walsh M.C., Szefler S., Davis J., et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 117 (2006) S52-S56
3. Waites K.B., Katz B., and Schelonka R.L. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 18 (2005) 757-789
4. Shepard M.C. The recovery of pleuropneumonia-like organisms from Negro men with and without nongonococcal urethritis. Am J Syph Gonor Vener Dis 38 (1954) 113-124
5. Klein J.O., Buckland D., and Finland M. Colonization of newborn infants by mycoplasmas. N Engl J Med 280 (1969) 1025-1030
6. Driscoll S.G., Kundsin R.B., Horne Jr. H.W., et al. Infections and first trimester losses: possible role of Mycoplasmas. Fertil Steril 20 (1969) 1017-1019
7. Schelonka R.L., Katz B., Waites K.B., et al. Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques. Pediatr Infect Dis J 24 (2005) 1033-1039
8. Cassell G.H., Waites K.B., and Crouse D.T. Mycoplasmal infections. In: Remington J.S., and Klein J.O. (Eds). Infectious Diseases of the Fetus and Newborn Infant (2001), WB Saunders, Philadelphia, PA 733-767
9. Cassell G.H., Waites K.B., Watson H.L., et al. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 6 (1993) 69-87
10. Cassell G.H., Davis R.O., Waites K.B., et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 10 suppl (1983) 294-302
11. Foulon W., Naessens A., Dewaele M., et al. Chronic Ureaplasma urealyticum amnionitis associated with abruptio placentae. Obstet Gynecol 68 (1986) 280-282
12. Gray D.J., Robinson H.B., Malone J., et al. Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 12 (1992) 111-117
13. Gerber S., Vial Y., Hohlfeld P., et al. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 187 (2003) 518-521
14. Colaizy T.T., Kuforiji T., Sklar R.S., et al. PCR methods in clinical investigations of human ureaplasmas: a minireview. Mol Genet Metab 80 (2003) 389-397
15. Cordero L., Coley B.D., Miller R.L., et al. Bacterial and Ureaplasma colonization of the airway: radiologic findings in infants with bronchopulmonary dysplasia. J Perinatol 17 (1997) 428-433
16. Kelly V.N., Garland S.M., and Gilbert G.L. Isolation of genital mycoplasmas from the blood of neonates and women with pelvic infection using conventional SPS-free blood culture media. Pathology 19 (1987) 277-280
17. Sanchez P.J., and Regan J.A. Vertical transmission of Ureaplasma urealyticum from mothers to preterm infants. Pediatr Infect Dis J 9 (1990) 398-401
18. Waites K.B., Crouse D.T., Philips III J.B., et al. Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn. Pediatrics 83 (1989) 79-85
19. Waites K.B., Rudd P.T., Crouse D.T., et al. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet 1 (1988) 17-21
20. Waites K.B., Duffy L.B., Crouse D.T., et al. Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population. Pediatr Infect Dis J 9 (1990) 241-245
21. Walsh W.F., Butler J., Coalson J., et al. A primate model of Ureaplasma urealyticum infection in the premature infant with hyaline membrane disease. Clin Infect Dis 17 suppl 1 (1993) S158-S162
22. Yoder B.A., Coalson J.J., Winter V.T., et al. Effects of antenatal colonization with Ureaplasma urealyticum on pulmonary disease in the immature baboon. Pediatr Res 54 (2003) 797-807
23. Tafari N., Ross S., Naeye R.L., et al. Mycoplasma T strains and perinatal death. Lancet 1 (1976) 108-109
24. Quinn P.A., Gillan J.E., Markestad T., et al. Intrauterine infection with Ureaplasma urealyticum as a cause of fatal neonatal pneumonia. Pediatr Infect Dis 4 (1985) 538-543
25. Crouse D.T., Odrezin G.T., Cutter G.R., et al. Radiographic changes associated with tracheal isolation of Ureaplasma urealyticum from neonates. Clin Infect Dis 17 suppl 1 (1993) S122-S130
26. Pacifico L., Panero A., Roggini M., et al. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. Pediatr Infect Dis J 16 (1997) 579-586
27. Panero A., Pacifico L., Rossi N., et al. Ureaplasma urealyticum as a cause of pneumonia in preterm infants: analysis of the white cell response. Arch Dis Child Fetal Neonatal Ed 73 (1995) F37-F40
28. Cassell G.H., Waites K.B., Gibbs R.S., et al. Role of Ureaplasma urealyticum in amnionitis. Pediatr Infect Dis 5 suppl (1986) S247-S252
29. Brus F., van Waarde W.M., Schoots C., et al. Fatal ureaplasmal pneumonia and sepsis in a newborn infant. Eur J Pediatr 150 (1991) 782-783
30. Ohlsson A., Wang E., and Vearncombe M. Leukocyte counts and colonization with Ureaplasma urealyticum in preterm neonates. Clin Infect Dis 17 suppl 1 (1993) S144-S147
31. Ollikainen J., Heiskanen-Kosma T., Korppi M., et al. Clinical relevance of Ureaplasma urealyticum colonization in preterm infants. Acta Paediatr 87 (1998) 1075-1078
32. De Dooy J.J., Mahieu L.M., and Van Bever H.P. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 160 (2001) 457-463
33. Groneck P., Schmale J., Soditt V., et al. Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. Pediatr Pulmonol 31 (2001) 331-338
34. Patterson A.M., Taciak V., Lovchik J., et al. Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J 17 (1998) 321-328
35. Viscardi R.M., Manimtim W.M., Sun C.C., et al. Lung pathology in premature infants with Ureaplasma urealyticum infection. Pediatr Dev Pathol 5 (2002) 141-150
36. Manimtim W.M., Hasday J.D., Hester L., et al. Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults. Infect Immun 69 (2001) 3906-3915
37. Viscardi R., Manimtim W., He J.R., et al. Disordered pulmonary myofibroblast distribution and elastin expression in preterm infants with Ureaplasma urealyticum pneumonitis. Pediatr Dev Pathol 9 (2006) 143-151
38. Li Y.H., Brauner A., Jonsson B., et al. Ureaplasma urealyticum-induced production of proinflammatory cytokines by macrophages. Pediatr Res 48 (2000) 114-119
39. Li Y.H., Brauner A., Jensen J.S., et al. Induction of human macrophage vascular endothelial growth factor and intercellular adhesion molecule-1 by Ureaplasma urealyticum and downregulation by steroids. Biol Neonate 82 (2002) 22-28
40. Li Y.H., Chen M., Brauner A., et al. Ureaplasma urealyticum induces apoptosis in human lung epithelial cells and macrophages. Biol Neonate 82 (2002) 166-173
41. Greenhalgh D.G. The role of apoptosis in wound healing. Int J Biochem Cell Biol 30 (1998) 1019-1030
42. Theilen U., Lyon A.J., Fitzgerald T., et al. Infection with Ureaplasma urealyticum: is there a specific clinical and radiological course in the preterm infant?. Arch Dis Child Fetal Neonatal Ed 89 (2004) F163-F167
43. Pacifico L., Panero A., Roggini M., et al. Ureaplasma urealyticum and pulmonary outcome in a neonatal intensive care population. Pediatr Infect Dis J 16 (1997) 579-586
44. Viscardi R.M., Kaplan J., Lovchik J.C., et al. Characterization of a murine model of Ureaplasma urealyticum pneumonia. Infect Immun 70 (2002) 5721-5729
45. Viscardi R.M., Atamas S.P., Luzina I.G., et al. Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res 60 (2006) 141-146
46. Crouse D.T., Cassell G.H., Waites K.B., et al. Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice. Infect Immun 58 (1990) 3487-3493
47. Rudd P.T., Cassell G.H., Waites K.B., et al. Ureaplasma urealyticum pneumonia: experimental production and demonstration of age-related susceptibility. Infect Immun 57 (1989) 918-925
48. Bancalari E., Claure N., and Sosenko I.R. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 8 (2003) 63-71
49. Cassell G.H., Waites K.B., Crouse D.T., et al. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet 2 (1988) 240-245
50. Wang E.E., Frayha H., Watts J., et al. Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J 7 (1988) 547-551
51. Sanchez P.J., and Regan J.A. Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants. Pediatr Infect Dis J 7 (1988) 542-546
52. Wang E.E., Ohlsson A., and Kellner J.D. Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis. J Pediatr 127 (1995) 640-644
53. Kong F., James G., Ma Z., et al. Phylogenetic analysis of Ureaplasma urealyticum: support for the establishment of a new species, Ureaplasma parvum. Int J Syst Bacteriol 49 (1999) 1879-1889
54. Pitcher D., Sillis M., and Robertson J.A. Simple method for determining biovar and serovar types of Ureaplasma urealyticum clinical isolates using PCR-single-strand conformation polymorphism analysis. J Clin Microbiol 39 (2001) 1840-1844
55. Robertson J.A., Vekris A., Bebear C., et al. Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum. J Clin Microbiol 31 (1993) 824-830
56. Heggie A.D., Bar-Shain D., Boxerbaum B., et al. Identification and quantification of ureaplasmas colonizing the respiratory tract and assessment of their role in the development of chronic lung disease in preterm infants. Pediatr Infect Dis J 20 (2001) 854-859
57. Abele-Horn M., Wolff C., Dressel P., et al. Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease. J Clin Microbiol 35 (1997) 1199-1202
58. Katz B., Patel P., Duffy L., et al. Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasia. J Clin Microbiol 43 (2005) 4852-4854
59. Northway Jr. W.H., Rosan R.C., and Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276 (1967) 357-368
60. Jobe A.J. The new BPD: an arrest of lung development. Pediatr Res 46 (1999) 641-643
61. Coalson J.J. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 8 (2003) 73-81
62. Coalson J.J. Pathology of bronchopulmonary dysplasia. Semin Perinatol 30 (2006) 179-184
63. Lyon A. Chronic lung disease of prematurity. The role of intra-uterine infection. Eur J Pediatr 159 (2000) 798-802
64. Baier R.J., Loggins J., and Kruger T.E. Failure of erythromycin to eliminate airway colonization with ureaplasma urealyticum in very low birth weight infants. BMC Pediatr 3 (2003) 10
65. Waites K.B., Sims P.J., Crouse D.T., et al. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection. Pediatr Infect Dis J 13 (1994) 287-293
66. Lyon A.J., McColm J., Middlemist L., et al. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 78 (1998) F10-F14
67. Jonsson B., Karell A.C., Ringertz S., et al. Neonatal Ureaplasma urealyticum colonization and chronic lung disease. Acta Paediatr 83 (1994) 927-930
68. Kenyon S.L., Taylor D.J., Tarnow-Mordi W., and ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 357 (2001) 979-988
69. Mabanta C.G., Pryhuber G.S., Weinberg G.A., et al. Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev 4 (2003) CD003744
70. Rylander M., and Hallander H.O. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Scand J Infect Dis 53 Suppl (1988) 12-17
71. Rumpianesi F., Morandotti G., Sperning R., et al. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline. J Chemother 5 (1993) 155-158
72. Matlow A., Th'ng C., Kovach D., et al. Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. Antimicrob Agents Chemother 42 (1998) 1290-1292
73. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 91 (1991) 40S0-5S
74. Luke D.R., Foulds G., Cohen S.F., et al. Safety, toleration, and pharmacokinetics of intravenous azithromycin. Antimicrob Agents Chemother 40 (1996) 2577-2581
75. Langtry H.D., and Balfour J.A. Azithromycin. A review of its use in paediatric infectious diseases. Drugs 56 (1998) 273-297
76. Rapp R.P. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions. Ann Pharmacother 32 (1998) 785-793
77. Tamaoki J., Kadota J., and Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med 117 suppl 9A (2004) 5S-11S
78. Ivetic T.V., Bosnjak B., Hrvacic B., et al. Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. Eur J Pharmacol 539 (2006) 131-138
79. Sanz M.J., Nabah Y.N., Cerda-Nicolas M., et al. Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression. Br J Pharmacol 144 (2005) 190-201
80. Kikuchi T., Hagiwara K., Honda Y., et al. Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors. J Antimicrob Chemother 49 (2002) 745-755
81. Bowman E.D., Dharmalingam A., Fan W.Q., et al. Impact of erythromycin on respiratory colonization of Ureaplasma urealyticum and the development of chronic lung disease in extremely low birth weight infants. Pediatr Infect Dis J 17 (1998) 615-620
82. Jonsson B., Rylander M., and Faxelius G. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatr 87 (1998) 1079-1084
83. Buhrer C., Hoehn T., and Hentschel J. Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum. Drugs 61 (2001) 1893-1899
84. Yoon B.H., Romero R., Kim K.S., et al. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 181 (1999) 773-779
85. Yoon B.H., Romero R., Jun J.K., et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177 (1997) 825-830
86. Short E.J., Klein N.K., Lewis B.A., et al. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 112 (2003) e359
87. Vohr B.R., Wright L.L., Poole W.K., et al. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998. Pediatrics 116 (2005) 635-643